NTRK2 and Alzheimer disease: It also inhibited p-JNK and caspase-3 activity in the liver of depressed rats (Kortam et al., 2021) and activated the BDNT/TrkB/AKT/CREB hub in an AD model (Abd El-Fatah et al., 2021).